122 related articles for article (PubMed ID: 18844490)
61. A microfluidic chip for rapid analysis of DNA melting curves for BRCA2 mutation screening.
Lin X; Nagl S
Lab Chip; 2020 Oct; 20(20):3824-3831. PubMed ID: 32926049
[TBL] [Abstract][Full Text] [Related]
62. Missense Variants of Uncertain Significance: A Powerful Genetic Tool for Function Discovery with Clinical Implications.
Sessa G; Ehlén Å; von Nicolai C; Carreira A
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359619
[TBL] [Abstract][Full Text] [Related]
63. 'A variant of uncertain significance' and the proliferation of human disease gene databases.
Nelson DR
Hum Genomics; 2005 Mar; 2(1):70-4. PubMed ID: 15814069
[TBL] [Abstract][Full Text] [Related]
64. [China expert consensus on BRCA variant interpretation].
Panel members of China expert consensus on BRCA variant interpretation
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):293-297. PubMed ID: 28468032
[No Abstract] [Full Text] [Related]
65. Re: familial multiple myeloma: a family study and review of the literature.
Sobol H; Vey N; Sauvan R; Philip N; Noguchi T; Eisinger F
J Natl Cancer Inst; 2002 Mar; 94(6):461-2; author reply 463. PubMed ID: 11904319
[No Abstract] [Full Text] [Related]
66. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.
Li H; Engel C; Hoya M; Peterlongo P; Yannoukakos D; Livraghi L; Radice P; Thomassen M; Hansen TVO; Gerdes AM; Nielsen HR; Caputo SM; Zambelli A; Borg A; Solano A; Thomas A; Parsons MT; Antoniou AC; Leslie G; Yang X; Chenevix-Trench G; Caldes T; Kwong A; Pedersen IS; Lautrup CK; John EM; Terry MB; Hopper JL; Southey MC; Andrulis IL; Tischkowitz M; Janavicius R; Boonen SE; Kroeldrup L; Varesco L; Hamann U; Vega A; Palmero EI; Garber J; Montagna M; Van Asperen CJ; Foretova L; Greene MH; Selkirk T; Moller P; Toland AE; Domchek SM; James PA; Thorne H; Eccles DM; Nielsen SM; Manoukian S; Pasini B; Caligo MA; Lazaro C; Kirk J; Wappenschmidt B; Spurdle AB; Couch FJ; Schmutzler R; Goldgar DE;
Genet Med; 2022 Oct; 24(10):2208. PubMed ID: 36205748
[No Abstract] [Full Text] [Related]
67. New approaches to BRCA1 mutation detection.
Hacia JG; Brody LC; Collins FS
Breast Dis; 1998 Apr; 10(1-2):45-59. PubMed ID: 15687548
[TBL] [Abstract][Full Text] [Related]
68. Correction: The frequency and pathogenicity of BRCA1 and BRCA2 variants in the general Japanese population.
Idogawa M; Mariya T; Tanaka Y; Saito T; Nakase H; Tokino T; Sakurai A
J Hum Genet; 2024 May; 69(5):231-234. PubMed ID: 38480854
[No Abstract] [Full Text] [Related]
69. Erratum to: High Resolution Melting Analysis is Very Useful to Identify BRCA1 c.4964_4982del19 (rs80359876) Founder Calabrian Pathogenic Variant on Peripheral Blood and Buccal Swab DNA.
Minucci A; De Bonis M; De Paolis E; Gentile L; Santonocito C; Concolino P; Mignone F; Capoluongo E
Mol Diagn Ther; 2017 Apr; 21(2):233. PubMed ID: 28266003
[No Abstract] [Full Text] [Related]
70. BRCA1 frameshift variants leading to extended incorrect protein C termini.
Nepomuceno TC; Foo TK; Richardson ME; Ranola JMO; Weyandt J; Varga MJ; Alarcon A; Gutierrez D; von Wachenfeldt A; Eriksson D; Kim R; Armel S; Iversen E; Couch FJ; Borg Å; Xia B; Carvalho MA; Monteiro ANA
HGG Adv; 2024 Apr; 5(3):100296. PubMed ID: 38669137
[No Abstract] [Full Text] [Related]
71. More on Co-Occurrence of COMT and BRCA1/2 Variants in a Population.
Chenevix-Trench G; Barnes DR; Antoniou AC
N Engl J Med; 2017 Aug; 377(8):793-5. PubMed ID: 28836424
[No Abstract] [Full Text] [Related]
72. Corrigendum to "Genetic identification of two Acipenser iridovirus-European variants using high-resolution melting analysis" [J. Virol. Methods 265 (2018) 105-112].
Pallandre L; Lesne M; de Boisséson C; Charrier A; Daniel P; Tragnan A; Debeuf B; Chesneau V; Bigarré L
J Virol Methods; 2019 Nov; 273():113661. PubMed ID: 31128946
[No Abstract] [Full Text] [Related]
73. BRCA1/2 population screening: embracing the benefits.
Plon SE
Curr Oncol; 2015 Aug; 22(4):e230-1. PubMed ID: 26300670
[No Abstract] [Full Text] [Related]
74. Correction to: In-Silico analyses of Nonsynonymous Variants in the BRCA1 Gene.
Arshad S; Ishaque I; Mumtaz S; Rashid MU; Malkani N
Biochem Genet; 2022 Aug; 60(4):1402-1407. PubMed ID: 34837577
[No Abstract] [Full Text] [Related]
75. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.
Borg A; Haile RW; Malone KE; Capanu M; Diep A; Törngren T; Teraoka S; Begg CB; Thomas DC; Concannon P; Mellemkjaer L; Bernstein L; Tellhed L; Xue S; Olson ER; Liang X; Dolle J; Børresen-Dale AL; Bernstein JL
Hum Mutat; 2010 Mar; 31(3):E1200-40. PubMed ID: 20104584
[TBL] [Abstract][Full Text] [Related]
76. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.
Houdayer C; Caux-Moncoutier V; Krieger S; Barrois M; Bonnet F; Bourdon V; Bronner M; Buisson M; Coulet F; Gaildrat P; Lefol C; Léone M; Mazoyer S; Muller D; Remenieras A; Révillion F; Rouleau E; Sokolowska J; Vert JP; Lidereau R; Soubrier F; Sobol H; Sevenet N; Bressac-de Paillerets B; Hardouin A; Tosi M; Sinilnikova OM; Stoppa-Lyonnet D
Hum Mutat; 2012 Aug; 33(8):1228-38. PubMed ID: 22505045
[TBL] [Abstract][Full Text] [Related]
77. Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations.
Maier C; Herkommer K; Luedeke M; Rinckleb A; Schrader M; Vogel W
Prostate; 2014 Oct; 74(14):1444-51. PubMed ID: 25111659
[TBL] [Abstract][Full Text] [Related]
78. A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing.
Ellison G; Huang S; Carr H; Wallace A; Ahdesmaki M; Bhaskar S; Mills J
BMC Clin Pathol; 2015; 15():5. PubMed ID: 25859162
[TBL] [Abstract][Full Text] [Related]
79. The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.
Stegel V; Krajc M; Zgajnar J; Teugels E; De Grève J; Hočevar M; Novaković S
BMC Med Genet; 2011 Jan; 12():9. PubMed ID: 21232165
[TBL] [Abstract][Full Text] [Related]
80. Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations.
Caminsky NG; Mucaki EJ; Perri AM; Lu R; Knoll JH; Rogan PK
Hum Mutat; 2016 Jul; 37(7):640-52. PubMed ID: 26898890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
